All Stories

  1. Does the global prevalence of heart failure now exceed 600 million people? From guesswork to evidence

    Article • European Heart Journal, May 2026, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  2. Congestion and renal function in patients with chronic heart failure

    Article • ESC Heart Failure, May 2026, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  3. Congestion, obesity and survival in chronic heart failure

    Article • Journal of Cardiac Failure, May 2026, Elsevier

    Dr Pierpaolo Pellicori

  4. Beyond Chronological Age: Why Frailty Matters in Heart Failure

    Article • European Journal of Heart Failure, April 2026, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  5. Do we need exercise echocardiography to diagnose HFpEF? Not at all

    Article • European Journal of Heart Failure, February 2026, Oxford University Press (OUP)

    Dr Matthew M Y Lee, Dr Pierpaolo Pellicori, Professor John GF Cleland

  6. Association between body mass index, plasma N-terminal pro-B-type natriuretic peptide, symptoms and outcome in patients referred for investigation of suspected heart failure

    Article • Heart, February 2026, BMJ

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  7. Effect of correcting iron deficiency on the risk of serious infection in heart failure: Insights from the IRONMAN trial

    Article • European Journal of Heart Failure, October 2024, Wiley

    Dr Pierpaolo Pellicori

  8. Managing congestive heart failure: It is mostly about water, not salt!

    Article • European Journal of Heart Failure, October 2024, Wiley

    Dr Pierpaolo Pellicori

  9. Adjudication of Hospitalizations and Deaths in the IRONMAN Trial of Intravenous Iron for Heart Failure

    Article • Journal of the American College of Cardiology, October 2024, Elsevier

    Dr Pierpaolo Pellicori

  10. Association of non-cardiac comorbidities and sex with long-term Re-hospitalization for heart failure

    Article • European Journal of Internal Medicine, October 2024, Elsevier

    Dr Pierpaolo Pellicori

  11. Effects of spironolactone on exercise blood pressure in patients at increased risk of developing heart failure: report from the HOMAGE trial

    Article • Hypertension Research, September 2024, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  12. Integrative assessment of congestion in heart failure using ultrasound imaging

    Article • Internal and Emergency Medicine, September 2024, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  13. REVOLUTION in Heart Failure Care and SELECT Highlights From the European Society of Cardiology-Heart Failure Association Heart Failure & World Congress on Acute Heart Failure 2024

    Article • Journal of Cardiac Failure, September 2024, Elsevier

    Dr Pierpaolo Pellicori

  14. Heart rate reactivity, recovery, and endurance of the incremental shuttle walk test in patients prone to heart failure

    Article • ESC Heart Failure, August 2024, Wiley

    Dr Pierpaolo Pellicori

  15. Disease progression in chronic heart failure is linear: Insights from multistate modelling

    Article • European Journal of Heart Failure, August 2024, Wiley

    Dr Pierpaolo Pellicori

  16. Managing water and salt balance in heart failure: Is there anything else to consider other than diet and diuretics?

    Article • European Journal of Heart Failure, July 2024, Wiley

    Dr Pierpaolo Pellicori

  17. Loop diuretic therapy with or without heart failure: impact on prognosis

    Article • European Heart Journal, June 2024, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  18. Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial

    Article • Heart, May 2024, BMJ

    Dr Pierpaolo Pellicori

  19. The Impact of Ferric Derisomaltose on Cardiovascular and Noncardiovascular Events in Patients With Anemia, Iron Deficiency, and Heart Failure With Reduced Ejection Fraction

    Article • Journal of Cardiac Failure, May 2024, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  20. Prognostic implication of lung ultrasound in heart failure: a pooled analysis of international cohorts

    Article • European Heart Journal - Cardiovascular Imaging, April 2024, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  21. Proteomic profiles of left atrial volume and its influence on response to spironolactone: Findings from the HOMAGE trial and STANISLAS cohort

    Article • European Journal of Heart Failure, March 2024, Wiley

    Dr Pierpaolo Pellicori

  22. Intravenous iron for heart failure, iron deficiency definitions, and clinical response: the IRONMAN trial

    Article • European Heart Journal, March 2024, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  23. Low Serum Ferritin Might Predict Incident Heart Failure

    Article • JACC Heart Failure, March 2024, Elsevier

    Dr Pierpaolo Pellicori

  24. Multi-modality assessment of congestion in acute heart failure: Associations with left ventricular ejection fraction and prognosis

    Article • Current Problems in Cardiology, March 2024, Elsevier

    Dr Pierpaolo Pellicori

  25. ACHIEVE conference proceedings: implementing action plans to reduce and control hypertension burden in Africa

    Article • February 2024, Springer Science + Business Media

    Paul Olowoyo, Dr Pierpaolo Pellicori

  26. Priorities to reduce the burden of hypertension in Africa through ACHIEVE

    Article • The Lancet Global Health, February 2024, Elsevier

    Paul Olowoyo, Dr Pierpaolo Pellicori

  27. Estimation of Right Atrial Pressure by Ultrasound-Assessed Jugular Vein Distensibility in Patients With Heart Failure

    Article • Circulation Heart Failure, February 2024, Wolters Kluwer Health

    Dr Pierpaolo Pellicori

  28. Reply to ‘Vasodilators in congestive heart failure: The perfect weapon aiming just off the target?’

    Article • European Journal of Heart Failure, February 2024, Wiley

    Dr Pierpaolo Pellicori

  29. Circulating cytokines and risk of developing hypertension: A systematic review and meta-analysis

    Article • Pharmacological Research, February 2024, Elsevier

    Dr Pierpaolo Pellicori

  30. Atrial myopathy and heart failure with preserved ejection fraction: When a label does more harm than good?

    Article • European Journal of Heart Failure, January 2024, Wiley

    Dr Pierpaolo Pellicori

  31. Medicines optimization prior to discharge in patients admitted to hospital with heart failure

    Article • ESC Heart Failure, January 2024, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  32. How to diagnose and treat venous congestion in heart failure

    Article • European Heart Journal, January 2024, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  33. Impact of vasodilators on diuretic response in patients with congestive heart failure: A mechanistic trial of cimlanod (BMS‐986231)

    Article • European Journal of Heart Failure, December 2023, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  34. Multiple Cardiac Biomarkers to Improve Prediction of Cardiovascular Events: Findings from the Generation Scotland Scottish Family Health Study

    Article • Clinical Chemistry, December 2023, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  35. Phenotyping patients with ischaemic heart disease at risk of developing heart failure: an analysis of the HOMAGE trial

    Article • ESC Heart Failure, November 2023, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland, Dr Joao Pedro Ferreira

  36. Hospital admissions in the last year of life of patients with heart failure

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, August 2023, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  37. Lung ultrasound in acute and chronic heart failure: a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI)

    Article • European Heart Journal - Cardiovascular Imaging, July 2023, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  38. Influence of serum transferrin concentration on diagnostic criteria for iron deficiency in chronic heart failure

    Article • ESC Heart Failure, July 2023, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  39. Coronary revascularization for heart failure with coronary artery disease: A systematic review and meta‐analysis of randomized trials

    Article • European Journal of Heart Failure, June 2023, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  40. Defining Heart Failure Based on Imaging the Heart and Beyond

    Article • Cardiac Failure Review, June 2023, Medical Media Communications, Ltd. T/A Radcliffe Cardiology

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  41. Assessment of haemoglobin and serum markers of iron deficiency in people with cardiovascular disease

    Article • Heart, May 2023, BMJ

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  42. Correction to: Congestion and Use of Diuretics in Heart Failure and Cardiomyopathies: A Practical Guide

    Article • Current Cardiology Reports, May 2023, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  43. Protein Biomarkers of New-Onset Heart Failure: Insights From the Heart Omics and Ageing Cohort, the Atherosclerosis Risk in Communities Study, and the Framingham Heart Study

    Article • Circulation Heart Failure, May 2023, Wolters Kluwer Health

    Dr Pierpaolo Pellicori, Professor John GF Cleland, Dr Joao Pedro Ferreira

  44. A machine learning‐derived echocardiographic algorithm identifies people at risk of heart failure with distinct cardiac structure, function, and response to spironolactone: findings from the HOMAGE trial

    Article • European Journal of Heart Failure, April 2023, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland, Dr Joao Pedro Ferreira

  45. Congestion and Use of Diuretics in Heart Failure and Cardiomyopathies: a Practical Guide

    Article • Current Cardiology Reports, April 2023, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  46. Urinary Proteomic Signature of Mineralocorticoid Receptor Antagonism by Spironolactone: Evidence from the Randomized-Controlled HOMAGE and PRIORITY Trials

    Article • April 2023, Cold Spring Harbor Laboratory Press

    Dr Pierpaolo Pellicori, Professor John GF Cleland, Dr Joao Pedro Ferreira

  47. Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials

    Article • International Journal of Cardiology, April 2023, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland, Dr Joao Pedro Ferreira

  48. Inferior vena cava diameter is associated with prognosis in patients with chronic heart failure independent of tricuspid regurgitation velocity

    Article • Clinical Research in Cardiology, March 2023, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  49. Intravenous iron in patients with heart failure and iron deficiency: an updated meta‐analysis

    Article • European Journal of Heart Failure, March 2023, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  50. Redefining both iron deficiency and anaemia in cardiovascular disease

    Article • European Heart Journal, March 2023, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  51. Effect of Spironolactone on QRS Duration in Patients at Risk for Heart Failure (from the HOMAGE Trial)

    Article • The American Journal of Cardiology, March 2023, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland, Dr Joao Pedro Ferreira

  52. Estimating nuclear scanning capacity requirements for patients with suspected cardiac transthyretin amyloidosis

    Article • ESC Heart Failure, February 2023, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  53. Editorial: Edema in heart failure with reduced ejection fraction

    Article • Frontiers in Cardiovascular Medicine, February 2023, Frontiers

    Dr Pierpaolo Pellicori

  54. Genetic architecture of the HLA/MHC locus in cardiometabolic disease, severe mental illness, and related traits.

    Article • January 2023, Research Square

    Dr Pierpaolo Pellicori

  55. The incremental value of multi-organ assessment of congestion using ultrasound in outpatients with heart failure

    Article • European Heart Journal - Cardiovascular Imaging, January 2023, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  56. Identification and quantification of congestion in heart failure: a work in progress

    Article • European Journal of Heart Failure, December 2022, Wiley

    Dr Pierpaolo Pellicori

  57. Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications

    Article • Clinical Research in Cardiology, December 2022, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  58. Which frailty tool best predicts morbidity and mortality in ambulatory patients with heart failure? A prospective study

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, November 2022, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  59. Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications

    Article • Clinical Research in Cardiology, November 2022, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  60. Spironolactone effect on cardiac structure and function of patients with heart failure and preserved ejection fraction: a pooled analysis of three randomized trials

    Article • European Journal of Heart Failure, November 2022, Wiley

    Dr Pierpaolo Pellicori, Dr Joao Pedro Ferreira

  61. Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

    Article • The Lancet, November 2022, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  62. Ketone Bodies in Acute Heart Failure: Fuel for Thought

    Article • Journal of Cardiac Failure, November 2022, Elsevier

    Dr Pierpaolo Pellicori

  63. Early and late renal function changes with spironolactone in patients at risk of developing heart failure: findings from the HOMAGE trial

    Article • Clinical Research in Cardiology, October 2022, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Dr Joao Pedro Ferreira

  64. Implanted haemodynamic telemonitoring devices to guide management of heart failure: a review and meta-analysis of randomised trials

    Article • Clinical Research in Cardiology, October 2022, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  65. Chronic kidney disease (CKD) and CKD ‐ism in heart failure – what a mess!

    Article • European Journal of Heart Failure, October 2022, Wiley

    Dr Pierpaolo Pellicori

  66. Optimal Management of Heart Failure and Chronic Obstructive Pulmonary Disease: Clinical Challenges

    Article • International Journal of General Medicine, October 2022, Taylor & Francis

    Dr Pierpaolo Pellicori

  67. Reply to ‘Particular challenges in the use of pulmonary vasodilating therapy for patients with pulmonary hypertension secondary to left heart disease’

    Article • European Journal of Heart Failure, September 2022, Wiley

    Dr Pierpaolo Pellicori

  68. Albuminuria as a marker of systemic congestion in patients with heart failure

    Article • European Heart Journal, September 2022, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  69. Dyskalemia in people at increased risk for heart failure: findings from the heart ‘OMics’ in AGEing (HOMAGE) trial

    Article • ESC Heart Failure, September 2022, Wiley

    Dr Pierpaolo Pellicori, Dr Joao Pedro Ferreira

  70. Inflammatory pathways in heart failure with preserved left ventricular ejection fraction: implications for future interventions

    Article • Cardiovascular Research, August 2022, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  71. Rationale and design of a randomised trial of intravenous iron in patients with heart failure

    Article • Heart, August 2022, BMJ

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  72. Clinical implications of left atrial changes after optimization of medical therapy in patients with heart failure

    Article • European Journal of Heart Failure, July 2022, Wiley

    Dr Pierpaolo Pellicori

  73. The association between markers of type I collagen synthesis and echocardiographic response to spironolactone in patients at risk of heart failure: findings from the HOMAGE trial

    Article • European Journal of Heart Failure, July 2022, Wiley

    Dr Pierpaolo Pellicori, Dr Joao Pedro Ferreira

  74. Dynamic risk stratification using Markov chain modelling in patients with chronic heart failure

    Article • ESC Heart Failure, June 2022, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  75. Are non-invasive estimations of plasma volume an accurate measure of congestion in patients with chronic heart failure?

    Article • European Heart Journal - Quality of Care and Clinical Outcomes, June 2022, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  76. Remote laser-speckle sensing of heart sounds for health assessment and biometric identification

    Article • Biomedical Optics Express, June 2022, Optical Society of America (OSA)

    Dr Pierpaolo Pellicori

  77. Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (the SilHF study): a randomized placebo‐controlled multicentre trial

    Article • European Journal of Heart Failure, June 2022, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  78. Heart failure: age is no excuse for complacency

    Article • European Journal of Heart Failure, May 2022, Wiley

    Dr Pierpaolo Pellicori

  79. Chronic Obstructive Pulmonary Disease and Heart Failure

    Article • Cardiology Clinics, May 2022, Elsevier

    Dr Pierpaolo Pellicori

  80. Predicting mortality after hospitalisation for COPD using electronic health records

    Article • Pharmacological Research, May 2022, Elsevier

    Dr Pierpaolo Pellicori

  81. Practical outpatient management of worsening chronic heart failure

    Article • European Journal of Heart Failure, April 2022, Wiley

    Dr Pierpaolo Pellicori

  82. Comparing and contrasting risk factors for heart failure in patients with and without history of myocardial infarction: data from HOMAGE and the UK Biobank

    Article • European Journal of Heart Failure, April 2022, Wiley

    Dr Pierpaolo Pellicori

  83. Therapeutic inertia in the pharmacological management of heart failure with reduced ejection fraction

    Article • ESC Heart Failure, April 2022, Wiley

    Dr Pierpaolo Pellicori

  84. Only people with increased plasma concentrations of natriuretic peptides should be included in outcome trials of diabetes, cardiovascular and kidney disease: implications for clinical practice

    Article • European Journal of Heart Failure, March 2022, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  85. Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial

    Article • European Journal of Heart Failure, March 2022, Wiley

    Dr Pierpaolo Pellicori, Dr Joao Pedro Ferreira

  86. Criteria for Iron Deficiency in Patients With Heart Failure

    Article • Journal of the American College of Cardiology, February 2022, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  87. Systemic administration of glucocorticoids, cardiovascular complications and mortality in patients hospitalised with COVID-19, SARS, MERS or influenza: A systematic review and meta-analysis of randomised trials

    Article • Pharmacological Research, February 2022, Elsevier

    Dr Pierpaolo Pellicori

  88. Assessment of Phasic Changes of Vascular Size by Automated Edge Tracking-State of the Art and Clinical Perspectives

    Article • Frontiers in Cardiovascular Medicine, January 2022, Frontiers

    Dr Pierpaolo Pellicori

  89. Prognostic Value and Therapeutic Utility of Lung Ultrasound in Acute and Chronic Heart Failure

    Article • JACC Cardiovascular Imaging, January 2022, Elsevier

    Dr Pierpaolo Pellicori

  90. Hypochloraemia following admission to hospital with heart failure is common and associated with an increased risk of readmission or death: a report from OPERA-HF

    Article • European Heart Journal Acute Cardiovascular Care, December 2021, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  91. Biomarker‐based assessment of collagen cross‐linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial

    Article • European Journal of Heart Failure, December 2021, Wiley

    Dr Pierpaolo Pellicori, Dr Joao Pedro Ferreira

  92. The Effect of Spironolactone in Patients With Obesity at Risk for Heart Failure: Proteomic Insights from the HOMAGE Trial

    Article • Journal of Cardiac Failure, December 2021, Elsevier

    Dr Pierpaolo Pellicori, Dr Joao Pedro Ferreira

  93. No influence of spironolactone on plasma concentrations of angiotensin-converting enzyme 2: Findings from the HOMAGE randomized trial

    Article • Archives of Cardiovascular Diseases, December 2021, Elsevier

    Dr Pierpaolo Pellicori

  94. The effect of digoxin on renal function in patients with heart failure

    Article • BMC Nephrology, October 2021, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  95. The prevalence and clinical associations of ultrasound measures of congestion in patients at risk of developing heart failure

    Article • European Journal of Heart Failure, October 2021, Wiley

    Dr Pierpaolo Pellicori

  96. Congestion in Patients with Advanced Heart Failure

    Article • Heart Failure Clinics, October 2021, Elsevier

    Dr Pierpaolo Pellicori

  97. To master heart failure, first master congestion

    Article • The Lancet, September 2021, Elsevier

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  98. Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: Implications for future trial design

    Article • Diabetes & Metabolism, September 2021, Elsevier

    Dr Pierpaolo Pellicori, Dr Joao Pedro Ferreira

  99. Proteomic mechanistic profile of patients with diabetes at risk of developing heart failure: insights from the HOMAGE trial

    Article • Cardiovascular Diabetology, August 2021, Springer Science + Business Media

    Professor John GF Cleland, Dr Pierpaolo Pellicori, Dr Joao Pedro Ferreira

  100. A novel treatment for heart failure targets myocardial fibrosis

    Article • Nature Reports Stem Cells, August 2021, Springer Science + Business Media

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  101. Ethnic differences in prevalence of actionable HbA1c levels in UK Biobank: implications for screening

    Article • BMJ Open Diabetes Research & Care, August 2021, BMJ

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  102. Use of Social Media by Cardiovascular Health Care Professionals

    Article • JACC Cardiovascular Imaging, August 2021, Elsevier

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  103. Reply to the letter regarding the article ‘Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure’

    Article • European Journal of Heart Failure, July 2021, Wiley

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  104. Remote history of VTE is associated with severe COVID‐19 in middle and older age: UK Biobank cohort study

    Article • Journal of Thrombosis and Haemostasis, July 2021, Wiley

    Professor John GF Cleland, Dr Pierpaolo Pellicori, Dr Evangelia Demou

  105. A comparison of non‐invasive methods of measuring body composition in patients with heart failure: a report from SICA‐HF

    Article • ESC Heart Failure, July 2021, Wiley

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  106. Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure

    Article • European Journal of Heart Failure, May 2021, Wiley

    Dr Pierpaolo Pellicori

  107. Use of diuretics and outcomes in patients with type 2 diabetes: Findings from the EMPA‐REG OUTCOME trial

    Article • European Journal of Heart Failure, May 2021, Wiley

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  108. Spironolactone effect on the blood pressure of patients at risk of developing heart failure: an analysis from the HOMAGE trial

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, April 2021, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori, Dr Joao Pedro Ferreira

  109. The struggle towards a Universal Definition of Heart Failure—how to proceed?

    Article • European Heart Journal, April 2021, Oxford University Press (OUP)

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  110. Proteomic and Mechanistic Analysis of Spironolactone in Patients at Risk for HF

    Article • JACC Heart Failure, April 2021, Elsevier

    Professor John GF Cleland, Dr Pierpaolo Pellicori, Dr Joao Pedro Ferreira

  111. Intravenous iron for heart failure with evidence of iron deficiency: a meta-analysis of randomised trials

    Article • Clinical Research in Cardiology, March 2021, Springer Science + Business Media

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  112. Prognostic value of the chest X-ray in patients hospitalised for heart failure

    Article • Clinical Research in Cardiology, March 2021, Springer Science + Business Media

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  113. The value of spot urinary creatinine as a marker of muscle wasting in patients with new‐onset or worsening heart failure

    Article • Journal of Cachexia Sarcopenia and Muscle, March 2021, Wiley

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  114. COVID-19 and its cardiovascular effects: a systematic review of prevalence studies

    Article • Cochrane Database of Systematic Reviews, March 2021, Wiley

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  115. The Effect of Digoxin on Renal Function in Patients with Heart Failure

    Article • February 2021, Research Square

    Dr Pierpaolo Pellicori

  116. The association between blood groups and COVID‐19 infection: a study from the UK Biobank

    Article • Journal of Internal Medicine, January 2021, Wiley

    Professor John GF Cleland, Dr Pierpaolo Pellicori

  117. Effect of frailty on treatment, hospitalisation and death in patients with chronic heart failure

    Article • Clinical Research in Cardiology, January 2021, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  118. The impact of malnutrition on short-term morbidity and mortality in ambulatory patients with heart failure

    Article • American Journal of Clinical Nutrition, November 2020, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  119. Ultrasound imaging of congestion in heart failure: examinations beyond the heart

    Article • European Journal of Heart Failure, November 2020, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  120. Early benefits of empagliflozin in patients with or without heart failure: findings from EMPA‐REG OUTCOME

    Article • ESC Heart Failure, September 2020, Wiley

    Dr Pierpaolo Pellicori

  121. Association between right-sided cardiac function and ultrasound-based pulmonary congestion on acutely decompensated heart failure: findings from a pooled analysis of four cohort studies

    Article • Clinical Research in Cardiology, August 2020, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  122. Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data

    Article • Therapeutics and Clinical Risk Management, August 2020, Taylor & Francis

    Dr Pierpaolo Pellicori

  123. Structural heart disease, cardiac dysfunction and heart failure: the ambiguity of a definition

    Article • European Journal of Preventive Cardiology, July 2020, SAGE Publications

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  124. Effects of danicamtiv, a novel cardiac myosin activator, in heart failure with reduced ejection fraction: experimental data and clinical results from a phase 2a trial

    Article • European Journal of Heart Failure, July 2020, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  125. Driving Habits and Reaction Times on a Driving Simulation in Older Drivers With Chronic Heart Failure

    Article • Journal of Cardiac Failure, July 2020, Elsevier

    Dr Pierpaolo Pellicori

  126. Caring for people with heart failure and many other medical problems through and beyond the COVID ‐19 pandemic: the advantages of universal access to home telemonitoring

    Article • European Journal of Heart Failure, June 2020, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  127. At the heart of COVID-19

    Article • European Heart Journal, May 2020, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  128. Association Between Walking Pace and Stroke Incidence

    Article • Stroke, May 2020, Wolters Kluwer Health

    Dr Pierpaolo Pellicori

  129. Ultrasound indices of congestion in patients with acute heart failure according to body mass index

    Article • Clinical Research in Cardiology, April 2020, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  130. Agreement and Classification Performance of Malnutrition Tools in Patients with Chronic Heart Failure

    Article • Current Developments in Nutrition, April 2020, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  131. Eplerenone prevents an increase in serum carboxy‐terminal propeptide of procollagen type I after myocardial infarction complicated by left ventricular dysfunction and/or heart failure

    Article • European Journal of Heart Failure, April 2020, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  132. Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept, randomised, precision‐medicine, prevention trial. The Heart OMics in AGing ...

    Article • European Journal of Heart Failure, January 2020, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland, Dr Joao Pedro Ferreira

  133. OUP accepted manuscript

    Article • European Heart Journal, January 2020, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori, Professor John GF Cleland, Dr Joao Pedro Ferreira

  134. Chronic Obstructive Pulmonary Disease and Heart Failure

    Article • Heart Failure Clinics, January 2020, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  135. Association of Fitness and Grip Strength With Heart Failure

    Article • Mayo Clinic Proceedings, November 2019, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  136. Myocardial Dysfunction and Coronary Artery Disease as Therapeutic Targets in Heart Failure

    Article • Circulation, August 2019, Wolters Kluwer Health

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  137. Prevalence and Incidence of Atrial Fibrillation in Ambulatory Patients with Heart Failure

    Article • The American Journal of Cardiology, August 2019, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  138. High sensitivity C-Reactive Protein in Chronic Heart Failure: Patient Characteristics, Phenotypes and Mode of Death

    Article • Cardiovascular Research, July 2019, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  139. New perspectives and future directions in the treatment of heart failure

    Article • Heart Failure Reviews, July 2019, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  140. Prevention or Procrastination for Heart Failure?

    Article • Journal of the American College of Cardiology, May 2019, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  141. Clinical and prognostic association of total atrial conduction time in patients with heart failure

    Article • Journal of Cardiovascular Medicine, April 2019, Wolters Kluwer Health

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  142. Identification of Frailty in Chronic Heart Failure

    Article • JACC Heart Failure, February 2019, Elsevier

    Dr Pierpaolo Pellicori

  143. Prevalence, pattern and clinical relevance of ultrasound indices of congestion in outpatients with heart failure

    Article • European Journal of Heart Failure, January 2019, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  144. The prognostic role of different renal function phenotypes in patients with acute heart failure

    Article • International Journal of Cardiology, November 2018, Elsevier

    Dr Pierpaolo Pellicori

  145. Dynamic risk stratification using serial measurements of plasma concentrations of natriuretic peptides in patients with heart failure

    Article • International Journal of Cardiology, October 2018, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  146. Walking Pace Is Associated with Lower Risk of All-Cause and Cause-Specific Mortality

    Article • Medicine & Science in Sports & Exercise, October 2018, Wolters Kluwer Health

    Dr Pierpaolo Pellicori

  147. Warm water immersion in patients with chronic heart failure: a pilot study

    Article • Clinical Research in Cardiology, September 2018, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  148. Malnutrition, congestion and mortality in ambulatory patients with heart failure

    Article • Heart, August 2018, BMJ

    Dr Pierpaolo Pellicori

  149. Effect of beta-adrenergic blockade on weight changes in patients with chronic heart failure

    Article • International Journal of Cardiology, August 2018, Elsevier

    Dr Pierpaolo Pellicori

  150. Iron deficiency in patients with heart failure with preserved ejection fraction and its association with reduced exercise capacity, muscle strength and quality of life

    Article • Clinical Research in Cardiology, July 2018, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  151. Losing Track by Tracking Speckles

    Article • JACC Cardiovascular Imaging, July 2018, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  152. Body mass index and all-cause mortality in heart failure patients with normal and reduced ventricular ejection fraction: a dose–response meta-analysis

    Article • Clinical Research in Cardiology, June 2018, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  153. Low serum chloride in patients with chronic heart failure: clinical associations and prognostic significance

    Article • European Journal of Heart Failure, June 2018, Wiley

    Dr Pierpaolo Pellicori

  154. Prevalence and Prognostic Significance of Malnutrition Using 3 Scoring Systems Among Outpatients With Heart Failure

    Article • JACC Heart Failure, June 2018, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  155. Effect of increased inspired oxygen on exercise performance in patients with heart failure and normal ejection fraction

    Article • International Journal of Cardiology, May 2018, Elsevier

    Dr Pierpaolo Pellicori

  156. Prognostic value of psychosocial factors for first and recurrent hospitalizations and mortality in heart failure patients: insights from the OPERA-HF study

    Article • European Journal of Heart Failure, January 2018, Wiley

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  157. Clinical and prognostic relationships of pulmonary artery to aorta diameter ratio in patients with heart failure: a cardiac magnetic resonance imaging study

    Article • Clinical Cardiology, January 2018, Wiley

    Dr Pierpaolo Pellicori

  158. Prevalence, predictors, and prognostic implications of PR interval prolongation in patients with heart failure

    Article • Clinical Research in Cardiology, September 2017, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  159. Time to Take the Failure Out of Heart Failure

    Article • JACC Heart Failure, July 2017, Elsevier

    Dr Pierpaolo Pellicori

  160. Interatrial shunt devices for heart failure with normal ejection fraction: a technology update

    Article • Medical Devices Evidence and Research, June 2017, Dove Medical Press

    Dr Pierpaolo Pellicori

  161. Pharmacological and Non-pharmacological Treatment for Decompensated Heart Failure: What Is New?

    Article • Current Heart Failure Reports, April 2017, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  162. This patient is not breathing properly: is this COPD, heart failure, or neither?

    Article • Expert Review of Cardiovascular Therapy, April 2017, Taylor & Francis

    Dr Pierpaolo Pellicori

  163. Takotsubo syndrome in the paediatric population

    Article • Journal of Cardiovascular Medicine, April 2017, Wolters Kluwer Health

    Dr Pierpaolo Pellicori

  164. Non-invasive measurement of right atrial pressure by near-infrared spectroscopy: preliminary experience. A report from the SICA-HF study

    Article • European Journal of Heart Failure, April 2017, Wiley

    Dr Pierpaolo Pellicori

  165. The effects of short-term omission of daily medication on the pathophysiology of heart failure

    Article • European Journal of Heart Failure, March 2017, Wiley

    Dr Pierpaolo Pellicori

  166. New pharmacological approaches in heart failure therapy: developments and possibilities

    Article • Future Cardiology, March 2017, Future Medicine

    Dr Pierpaolo Pellicori

  167. What proportion of patients with chronic heart failure are eligible for sacubitril-valsartan?

    Article • European Journal of Heart Failure, February 2017, Wiley

    Dr Pierpaolo Pellicori

  168. Prognostic value of simple frailty and malnutrition screening tools in patients with acute heart failure due to left ventricular systolic dysfunction

    Article • Clinical Research in Cardiology, February 2017, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  169. Terapia diuretica nell’insufficienza cardiaca cronica: evidenze, esperienze, prospettive

    Article • Giornale Italiano di Cardiologia, February 2017, Il Pensiero Scientifico Editore

    Dr Pierpaolo Pellicori

  170. Is Swimming Safe in Heart Failure? A Systematic Review

    Article • Cardiology in Review, January 2017, Wolters Kluwer Health

    Dr Pierpaolo Pellicori

  171. Renal function estimation and Cockcroft–Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart ‘OMics’ in AGEing (HOMAGE) and the high-risk myocar...

    Article • BMC Medicine, November 2016, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor john j mcmurray

  172. Cardiac Dysfunction, Congestion and Loop Diuretics: their Relationship to Prognosis in Heart Failure

    Article • Cardiovascular Drugs and Therapy, November 2016, Springer Science + Business Media

    Dr Pierpaolo Pellicori

  173. Sarcopenia in patients with heart failure with preserved ejection fraction: Impact on muscle strength, exercise capacity and quality of life

    Article • International Journal of Cardiology, November 2016, Elsevier

    Dr Pierpaolo Pellicori

  174. Tachycardia-induced cardiomyopathy in pregnancy

    Article • Journal of Cardiovascular Medicine, October 2016, Wolters Kluwer Health

    Dr Pierpaolo Pellicori

  175. PARADIGM-HF: does dose matter?

    Article • European Journal of Heart Failure, October 2016, Wiley

    Dr Pierpaolo Pellicori

  176. Prevalence and Outcomes of Anemia and Hematinic Deficiencies in Patients With Chronic Heart Failure

    Article • JAMA Cardiology, August 2016, American Medical Association (AMA)

    Dr Pierpaolo Pellicori

  177. Taxonomy of segmental myocardial systolic dysfunction

    Article • European Heart Journal, May 2016, European Society of Cardiology

    Dr Pierpaolo Pellicori

  178. Regional circulatory distribution of novel cardiac bio-markers and their relationships with haemodynamic measurements

    Article • International Journal of Cardiology, May 2016, Elsevier

    Dr Pierpaolo Pellicori

  179. New ways to visualize and combat congestion in heart failure

    Article • Revista Clínica Española, May 2016, Elsevier

    Dr Pierpaolo Pellicori

  180. Is the diagnostic coding position of acute heart failure related to mortality? A report from the Euro Heart Failure Survey-1

    Article • European Journal of Heart Failure, March 2016, Wiley

    Dr Pierpaolo Pellicori

  181. The effect of increasing inspired oxygen on exercise performance in patients with chronic heart failure

    Article • Heart, February 2016, BMJ

    Dr Pierpaolo Pellicori

  182. Exploring quality of life in patients with and without heart failure

    Article • International Journal of Cardiology, January 2016, Elsevier

    Dr Pierpaolo Pellicori

  183. Betabloccanti in pazienti con scompenso cardiaco e fibrillazione atriale

    Article • Giornale Italiano di Cardiologia, November 2015, Il Pensiero Scientifico Editore

    Dr Pierpaolo Pellicori

  184. Clinical trials update from the European Society of Cardiology-Heart Failure meeting 2015: AUGMENT-HF, TITRATION, STOP-HF, HARMONIZE, LION HEART, MOOD-HF, and renin-angiotensin inhibitors in patients with heart and renal failure

    Article • European Journal of Heart Failure, August 2015, Wiley

    Dr Pierpaolo Pellicori

  185. The Prevalence of Iron Deficiency in Patients with Heart Failure with Preserved Ejection Fraction and its Association with Elevated Pulmonary Pressure, Reduced Exercise Capacity and Quality of Life

    Article • Journal of Cardiac Failure, August 2015, Elsevier

    Dr Pierpaolo Pellicori

  186. Prognostic significance of ultrasound-assessed jugular vein distensibility in heart failure

    Article • Heart, May 2015, BMJ

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  187. The Obesity Paradox in Type 2 Diabetes Mellitus: Relationship of Body Mass Index to Prognosis

    Article • Annals of Internal Medicine, May 2015, American College of Physicians

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  188. The relationship of QRS morphology with cardiac structure and function in patients with heart failure

    Article • Clinical Research in Cardiology, April 2015, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  189. If home telemonitoring reduces mortality in heart failure, is this just due to better guideline-based treatment?

    Article • Journal of Telemedicine and Telecare, March 2015, SAGE Publications

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  190. Update on management of heart failure with preserved ejection fraction

    Article • Current Opinion in Cardiology, March 2015, Wolters Kluwer Health

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  191. Prescribing Patterns to Optimize Heart Rate

    Article • JACC Heart Failure, March 2015, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  192. Is the Epidemic of Heart Disease Really Over or Just Evolving?

    Article • The American Journal of Medicine, March 2015, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  193. Patent Ductus Arteriosus in Older Adults: Incidental Finding or Relevant Pathology?

    Article • Journal of the American Geriatrics Society, February 2015, Wiley

    Dr Pierpaolo Pellicori

  194. The Prevalence of Extra-cranial Carotid Artery Disease in Chronic Heart Failure

    Article • Cardiology and Angiology An International Journal, January 2015, Sciencedomain International

    Dr Pierpaolo Pellicori

  195. Fluid Management In Patients With Chronic Heart Failure

    Article • January 2015, Medical Media Communications, Ltd. T/A Radcliffe Cardiology

    Dr Pierpaolo Pellicori

  196. Heart failure with preserved ejection fraction

    Article • Clinical Medicine, December 2014, Royal College of Physicians

    Dr Pierpaolo Pellicori

  197. Clinical trials update from the European Society of Cardiology meeting 2014: PARADIGM‐HF, CONFIRM‐HF, SIGNIFY, atrial fibrillation, beta‐blockers and heart failure, and vagal stimulation in heart failure

    Article • ESC Heart Failure, November 2014, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori

  198. Left atrial function measured by cardiac magnetic resonance imaging in patients with heart failure: clinical associations and prognostic value

    Article • European Heart Journal, October 2014, European Society of Cardiology

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  199. Lipid-Modifying Treatments for Heart Failure

    Article • Heart Failure Clinics, October 2014, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  200. Does Speckle Tracking Really Improve Diagnosis and Risk Stratification in Patients With HF With Normal EF?

    Article • Journal of the American College of Cardiology, October 2014, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  201. Diagnostic Accuracy of Left Ventricular Systolic Dysfunction in Routine Clinical Practice-Classifying the Unclassified

    Article • Journal of Cardiac Failure, August 2014, Elsevier

    Dr Pierpaolo Pellicori

  202. Muscle Wasting in Patients with Heart Failure with Preserved Ejection Fraction and Its Impact on Muscle Strength and Functional Capacity during Exercise

    Article • Journal of Cardiac Failure, August 2014, Elsevier

    Dr Pierpaolo Pellicori, Professor Wolfram Doehner

  203. Remote telemonitoring for patients with heart failure: might monitoring pulmonary artery pressure become routine?

    Article • Expert Review of Cardiovascular Therapy, July 2014, Taylor & Francis

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  204. Clinical Trials in Patients with Heart Failure and Preserved Left Ventricular Ejection Fraction

    Article • Heart Failure Clinics, July 2014, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  205. Telemonitoring in heart failure: Big Brother watching over you

    Article • Heart Failure Reviews, June 2014, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  206. THE OBESITY PARADOX IN TYPE II DIABETES MELLITUS: IMPACT OF BODY MASS INDEX ON PROGNOSIS

    Article • Journal of the American College of Cardiology, April 2014, Elsevier

    Dr Pierpaolo Pellicori

  207. Multiple Cardiac Clots in an Individual with Essential Thrombocythemia and Heart Failure

    Article • Journal of the American Geriatrics Society, March 2014, Wiley

    Dr Pierpaolo Pellicori

  208. The in vitro stability of novel cardiovascular and sepsis biomarkers at ambient temperature

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2014, De Gruyter

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  209. Revisiting a classical clinical sign: Jugular venous ultrasound

    Article • International Journal of Cardiology, January 2014, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  210. Global longitudinal strain in patients with suspected heart failure and a normal ejection fraction: does it improve diagnosis and risk stratification?

    Article • The International Journal of Cardiovascular Imaging, October 2013, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  211. Case Selection for Cardiac Resynchronization in Atrial Fibrillation

    Article • Heart Failure Clinics, October 2013, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  212. Old and newer biomarkers in heart failure

    Article • Journal of Cardiovascular Medicine, October 2013, Wolters Kluwer Health

    Dr Pierpaolo Pellicori

  213. Does cirrhotic cardiomyopathy exist? 50 years of uncertainty

    Article • Clinical Research in Cardiology, September 2013, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  214. Intravenous versus intracoronary bolus of glycoprotein IIb/IIIa inhibitor administration during primary percutaneous coronary intervention on long-term left ventricular systolic and diastolic function

    Article • Cardiology Journal, June 2013, VM Media SP. zo.o VM Group SK

    Dr Pierpaolo Pellicori

  215. Why Does CRT Reduce the Risk of Arrhythmias?

    Article • JACC Cardiovascular Imaging, April 2013, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  216. Fish Oil vs Olive Oil for Postoperative Atrial Fibrillation

    Article • JAMA, March 2013, American Medical Association (AMA)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  217. Cardiac dysfunction in cirrhosis is not associated with the severity of liver disease

    Article • European Journal of Internal Medicine, March 2013, Elsevier

    Dr Pierpaolo Pellicori

  218. Defining Diastolic Heart Failure and Identifying Effective Therapies

    Article • JAMA, February 2013, American Medical Association (AMA)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  219. Medical Management of Stable Coronary Atherosclerosis

    Article • Current Atherosclerosis Reports, February 2013, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  220. IVC Diameter in Patients With Chronic Heart Failure

    Article • JACC Cardiovascular Imaging, January 2013, Elsevier

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  221. An atrial mass

    Article • Journal of Cardiovascular Medicine, November 2012, Wolters Kluwer Health

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  222. A Meta-Analysis of the Therapeutic Effects of Glucagon-Like Peptide-1 Agonist in Heart Failure

    Article • International Journal of Peptides, July 2012, Hindawi Publishing Corporation

    Dr Pierpaolo Pellicori

  223. Renal dysfunction in acute and chronic heart failure: prevalence, incidence and prognosis

    Article • Heart Failure Reviews, March 2012, Springer Science + Business Media

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  224. Subclinical Anthracycline Cardiotoxicity in Patients With Acute Promyelocytic Leukemia in Long‐Term Remission After the AIDA Protocol

    Article • Congestive Heart Failure, January 2012, Wiley

    Dr Pierpaolo Pellicori

  225. Clinical Trials Update from the American Heart Association Meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT

    Article • European Journal of Heart Failure, April 2011, Oxford University Press (OUP)

    Dr Pierpaolo Pellicori, Professor John GF Cleland

  226. Cor triatriatum: Transoesophageal three-dimensional reconstruction shows exact membrane morphology

    Article • Archives of Cardiovascular Diseases, March 2010, Elsevier

    Dr Pierpaolo Pellicori